Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination
Epidemiologist and health security expert says clinicians should prepare for monkeypox
23 May 2022Price and convenience can drive consumers to purchase cannabis from illegal, rather than legal, sources
24 May 2022Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination
A study co-led by the Universities of Oxford, Birmingham and Southampton and the U.K. Health Security Agency (UKHSA), published in Lancet Oncology today by the U.K. Coronavirus Cancer Evaluation Project, has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalization and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.
